The zebrafish is a powerful vertebrate model for studies of development and genetics1,2. Zebrafish and humans share high genetic homology (70% of the genes are shared with the human genome), which allows its use as a model for human diseases3. In zebrafish, it is quite common to detect the expression patterns of two genes and their spatial relationship. Immunohistochemistry was first used in 1941 to detect pathogens in infected tissues by applying FITC-labeled antibodies4. The target protein in the tissue section is first labeled with a primary antibody, and the section is then labeled with a secondary antibody against the primary antibody's host species immunoglobulin. Antibody staining is a robust approach to detect the localization of proteins, which offers high optical resolution at the intracellular level. However, the number of antibodies available is very limited in zebrafish. A recent study shows that approximately 112,000 antibodies are commercially available for mice; however, very few antibodies have been demonstrated to be reliable in zebrafish5.
Instead, in zebrafish, in situ hybridization has been widely applied for gene expression pattern analysis. This method was first used to assess gene expression in Drosophila embryos in the 1980s6,7, and since then, this technology has been continuously developed and improved. Initially, radiolabeled DNA probes were used to detect mRNA transcripts; however, the spatial resolution was relatively low, and there were potential health risks caused by the radioactivity. Subsequently, in situ hybridization relies on the RNA probes labeled with digoxigenin (DIG) or fluorescein (Fluo), which are conjugated to alkaline phosphatase (AP) or detected by fluorescent tyramide signal amplification (TSA)8,9. Although TSA has been used to detect two or three genes, DIG labeling of RNA probes and antiDIG AP-conjugated antibody are still highly sensitive, stable, and widely used approaches for in situ hybridization. Therefore, commercialized antibodies combined with DIG-labeled in situ probes are useful for providing insight into protein localization and expression of one gene.
Whole-mount embryos cannot reveal the spatial relationship between genes due to the low optical resolution, even though zebrafish embryos are small and transparent10. Hence, sectioning is necessary to analyze the expression patterns of genes at the intracellular level. Cryosectioning has been widely used in zebrafish as it is easy to perform and can effectively preserve the antigen. Therefore, in situ hybridization combined with immunohistochemistry in zebrafish cryosections offers a powerful way for analyzing the expression patterns of two genes. A combination of in situ hybridization and immunohistochemistry has been applied to zebrafish11. However, proteinase K treatment was used to enhance probe penetration at the expense of antigen integrity. To overcome this limitation, this protocol uses heating to induce antigen retrieval. This protocol is not only applicable to embryos of different stages and tissue sections of various thicknesses (14 µm head sections and 20 µm spinal cord sections), but it has also been verified by using genes expressed in two organs, including the head and spinal cord.
This article will describe how to combine in situ hybridization and antibody staining in zebrafish embryos in cryosections. The versatility of this protocol is demonstrated by using a number of in situ hybridization-immunohistochemistry combinations, including in situ hybridization probes for two different neurons. This method is suitable for detecting mRNA and protein in different regions and embryos of different ages, as well as the expression patterns of two genes.